Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 2021
- PMID: 40455410
- PMCID: PMC12915880
- DOI: 10.1080/21645515.2025.2500261
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 2021
Abstract
Understanding rotavirus prevalence by genotype can inform disease prevention and immunization decision-making. This systematic literature review summarized the genotype-specific prevalence of rotavirus in Asia from 2015 to 2021. We identified surveillance studies using PubMed, Embase, and Scopus databases, and used proportional meta-analysis (with the generic inverse variance method with arcsine transformation and generalized linear mixed models) to summarize genotype prevalence by region. A total of 7,601 studies were screened, and 73 studies from 16 countries were included. Data from 19,935 rotavirus samples reveal that the most common rotavirus genotypes circulating in Asia from 2015 to 2021 were G3P[8] (24%; 95% CI: 19%, 30%), G9P[8] (11%; 95% CI: 7%, 16%), G1P[8] (11%; 95% CI: 8%, 14%) and G2P[4] (8%; 95% CI: 6%, 10%). The results are comparable to estimates from the pre-vaccine licensure period. Surveillance based on sequencing data could help detect more subtle changes and further characterize the rotavirus burden in Asia.
Keywords: Rotavirus; child health; diarrhoea; epidemiology; vaccination.
Plain language summary
This study synthesizes data on rotavirus prevalence by genotype in Asia for the period 2015–2021. It finds G3P[8], G9P[8], G1P[8] and G2P[4] to be the most prevalent genotypes across the included countries.
Conflict of interest statement
Sharomi Oluwaseun and Cristina Carias are employed by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and shareholders of Merck & Co., Inc., Rahway, NJ, USA, which manufactures RotaTeq©. Triangulate Health Ltd received funding from by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA to complete this study and employed Chrissy Bishop, Christian Hauck, Hannah Schirrmacher, Maria Bermudez and Tim Jesudason during the study. Triangulate Health Ltd also provided funding for Kelly Fleetwood through a sub-contract. Daniel Hungerford received consulting fees and honorarium from Merck & Co., Inc., Rahway, NJ, USA, and institutional grants from Seqirus UK Ltd, Merck & Co., Inc., Rahway, NJ, USA, and GlaxoSmithKline Biologicals. Jelle Matthijnssens also received consulting fees from GlaxoSmithKline and Merck & Co., Inc., Rahway, NJ, USA.
Figures
References
-
- ICTV . History of the taxon: species: rotavirus alphagastroenteritis. 2024. [accessed 2024 Oct 2]. https://ictv.global/taxonomy/taxondetails?taxnode_id=202304905&taxon_nam...]. p. 1–10.
-
- Esona MD, Steele D, Kerin T, Armah G, Peenze I, Geyer A, Page N, Nyangao J, Agbaya V, Trabelsi A, et al. Determination of the G and P types of Previously nontypeable rotavirus strains from the African rotavirus network, 1996–2004: identification of unusual G types. J Infect Dis. 2010;202(SUPPL 1):S49–S54. doi: 10.1086/653552. - DOI - PubMed
-
- Fields BN, Knipe DM, Howley PM.. Fields virology. Vol. 2. 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2007.
-
- Bányai K, László B, Duque J, Steele DA, Nelson EAS, Gentsch JR, Parashar UD. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine. 2012;30:A122–30. doi: 10.1016/j.vaccine.2011.09.111. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical